SURMOUNT-OSA extension data: what happens after the trial stops
A design note rather than a result: what the comparator was, and what that permits you to conclude.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 8 of 8 of this archive, newest first.
A design note rather than a result: what the comparator was, and what that permits you to conclude.
Almost every figure in circulation about tolerability comes from six publications. This is what they say.